Dr Joakim Crona provides an overview of practice changing clinical trials within the field of neuroendocrine tumours and neuroendocrine carcinomas
Dr Joakim Crona provides an overview of practice changing clinical trials within the field of neuroendocrine tumours and neuroendocrine carcinomas
Joakim Crona is a resident in clinical oncology and associate professor in molecular oncology at Uppsala Academic Hospital, Sweden. He’s had a particular interest for neuroendocrine tumors since more than eight years. This included successfully defending his thesis covering genetics of neuroendocrine tumors, as well as working as a physician at the clinic of endocrine oncology. Joakim has just returned from a short term fellowship at the Pheochromocytoma/Paraganglioma Program, US National Institutes of Health. He plans a future career in the field of endocrine oncology that will unite clinical science with molecular biology, aiming at improving treatment of patients with these rare diseases.
Novartis.
On-demand materials from an Experts Knowledge Share event
Points de vue d’experts sur les dernières données concernant le cancer neuroendocrinien
5 MIN
Mar 2026
Experts share their views on latest data in neuroendocrine cancer
5 MIN
Mar 2026
Clinical insights and expert discussion